LFA-3Leukocyte Function-Associated Antigen-3 (protein)
References in periodicals archive ?
LFA-3 isa component of TRICOM, Therion's co-stimulatory system for optimizingimmune response against tumor cells.
Under the terms of this agreement, Therion gains a non-exclusive license under the LFA-3 patent rights to develop, manufacture and commercialize oncology product candidates incorporating the LFA-3 co- stimulatory molecule.
1 and LFA-3, to enhance antigen presentation and activation of immune responses critical for tumor destruction.